XML 49 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 1 - Summary of Significant Interim Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2013
Accounting Policies [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

Three Months

Ended September 30,

   

Nine Months

Ended September 30,

 
   

2013

   

2012

   

2013

   

2012

 

Net earnings used in the computation of basic and diluted earnings per share

  $ 1,508,000     $ 1,242,000     $ 4,175,000     $ 2,546,000  
                                 

Weighted average shares outstanding - basic

    6,346,260       6,063,269       6,197,921       6,051,795  

Common stock equivalents

    57,633       84,743       49,909       92,076  

Weighted average shares outstanding - diluted

    6,403,893       6,148,012       6,247,830       6,143,871  
                                 

Per Share Data :

                               

Basic

                               

Net earnings

  $ 0.24     $ 0.20     $ 0.67     $ 0.42  
                                 

Diluted

                               

Net earnings

  $ 0.24     $ 0.20     $ 0.67     $ 0.41  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
   

No. of

Shares

   

Weighted Average

Exercise Price

 

Outstanding December 31, 2012

    614,917     $ 11.24  

Granted

    202,884       11.43  

Exercised

    (34,758 )     9.19  

Lapsed

    (31,150 )     10.68  

Cancelled

    (21,481 )     11.66  

Outstanding September 30, 2013

    730,412     $ 11.40  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
   

No. of

Shares

   

Weighted Average

Exercise Price

 

Outstanding December 31, 2012

    176,476     $ 11.60  

Granted

    59,716       11.29  

Exercised

    -       -  

Lapsed

    -       -  

Cancelled

    -       -  

Outstanding September 30, 2013

    236,192     $ 11.52  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

Three Months Ended September 30,

 
   

SARS

   

Options

 
                   

Exercise price

                 

2013

   

N/A

    $11.76 -   

2012

   

N/A

      $11.72    
                   

Market price

                 

2013

   

N/A

      $11.76    

2012

   

N/A

      $11.72    
                   

Risk free interest rate (1)

                 

2013

   

N/A

      1.4%    

2012

   

N/A

      0.7%    
                   

Expected award life (years) (2)

   

N/A

      5    
                   

Expected volatility (3)

                 

2013

   

N/A

      45.7%    

2012

   

N/A

      45.9%    
                   

Expected dividend yield (4)

                 

2013

   

N/A

      4.6%    

2012

   

N/A

      4.6%    
   

Nine Months Ended September 30,

 
   

SARS

   

Options

 
                   

Exercise price

                 

2013

    $11.29     $11.29  - $11.76  

2012

    $13.15     $11.72  - $13.15  
                   

Market price

                 

2013

    $11.29     $11.29  - $11.76  

2012

    $13.15     $11.72  - $13.15  
                   

Risk free interest rate (1)

                 

2013

    0.9%      0.9%  - 1.7%  

2012

    0.8%      0.7%  - 1.9%  
                   

Expected award life (years) (2)

    5      5 - 10  
                   

Expected volatility (3)

                 

2013

    46.0%      36.7%  - 46.0%  

2012

    45.1%      36.4%  - 45.9%  
                   

Expected dividend yield (4)

                 

2013

    4.8%      4.6%  - 4.8%  

2012

    4.1%      4.1%  - 4.6%